AF
TXG icon

Advisornet Financial’s 10x Genomics TXG Stock Holding History

Advisornet Financial’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-15
Closed -$175 – 2358
2025
Q3 		$175 Buy
+15
New +$196 ﹤0.01% 2167
2025
Q2 		– Sell
-18
Closed -$157 – 2368
2025
Q1 		$157 Hold
18
– – ﹤0.01% 2090
2024
Q4 		$258 Hold
18
– – ﹤0.01% 1860
2024
Q3 		$406 Sell
18
-27
-60% -$558 ﹤0.01% 2043
2024
Q2 		$875 Buy
+45
New +$1.18K ﹤0.01% 1845
2023
Q3 		– Sell
-10
Closed -$558 – 2418
2023
Q2 		$558 Hold
10
– – ﹤0.01% 2033
2023
Q1 		$558 Hold
10
– – ﹤0.01% 2044
2022
Q4 		$364 Buy
+10
New +$327 ﹤0.01% 2091
2022
Q3 		– Sell
-5
Closed – – 2049
2022
Q2 		$0 Sell
5
-10
-67% -$519 ﹤0.01% 2141
2022
Q1 		$1K Buy
+15
New +$1.31K ﹤0.01% 1938

Other funds holding TXG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Advisornet Financial's TXG Position: Q4 2025 in Review

Advisornet Financial sold out of 10x Genomics (TXG) in Q4 2025, closing a stake of 15 shares — an estimated $175 sold.

Advisornet Financial first reported a position in TXG in Q1 2022 and held it in 10 quarters. The position peaked at $1K in Q1 2022. 322 funds tracked by Wall St. Rank hold TXG as of Q4 2025.

  • Advisornet Financial reported no remaining 10x Genomics position as of Q4 2025 after selling out during the quarter.
  • Advisornet Financial sold 15 10x Genomics shares in Q4 2025, an estimated $175.
  • Advisornet Financial first reported a position in 10x Genomics in Q1 2022 and held it in 10 quarters.
  • Advisornet Financial's 10x Genomics position peaked at $1K in Q1 2022.
  • 322 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2025.

Based on Advisornet Financial's 13F filing for Q4 2025, filed 20 Jan 2026.